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Objectives: Capsular contracture is a common complication associated with recon-
structive breast surgery. The optimal time interval between the completion of tissue
expansion and placement of the permanent implant is arbitrary and incompletely stud-
ied in the literature. The aim of the study was to determine whether the time interval
between completion of expansion and placement of the permanent implant would affect
the incidence of capsular contracture. Methods: We conducted a retrospective study of
112 patients with breast cancer, including 140 breasts, who underwent postmastectomy
tissue expander placement between 1997 and 2004. All patients underwent replacement
of tissue expander with a permanent prosthesis. Data were collected retrospectively, in-
cluding whether the patient smoked, underwent radiation therapy, had saline or silicone
implant reconstruction, required reoperation after tissue expander placement or after
permanent implant placement, Baker classification, and the interval between comple-
tion of expansion and placement of permanent implant. Results: We used a logistic
regression model to incorporate the predictors of capsular contracture. Keeping all other
predictors constant, we found that the time interval between implant exchange had no
effect on capsular contracture. The only significant predictor of capsular contracture
wasw hether the patient required a reoperation after the permanent implant was placed
(P=.0001).Conclusions:Allowingthecapsulearoundatissueexpandertomaturedoes
not significantly affect development of capsular contracture. However, a complication
that necessitates disrupting the periprosthetic capsule of the permanent implant with an
operation significantly increases odds of developing contracture.
In implant-based breast reconstruction, a prosthetic tissue expander is placed in a
pocket beneath breast skin and muscle after mastectomy and expanded over a period of
weeks to months. Once a goal volume is reached and the soft tissue envelope has been
adequately expanded, the temporary expander is removed and a permanent implant is
placed. This technique, described independently in 1982 by both Austad and Radovan,
uses local tissue to reconstruct the breast, offering the advantage of a color and texture
match.1,2
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Aninevitableconsequenceofusingbreastimplantsforpostmastectomyreconstruction
isformationofaperiprostheticcapsule.Thecapsuleformsaspartofaphysiologicresponse
to a foreign body. The periprosthetic capsule is both too large to be digested by the immune
system and too inert to elicit rejection.3,4 Although the capsule initially keeps the implant
in its proper position in the breast, over time, many women will experience a hardening and
tightening of the capsule known as capsular contracture. Capsular contracture is thought to
result from a prolonged process of tissue repair as a response to the presence of a foreign
body.5 Although surgical technique and the quality of breast prostheses have significantly
improved over time, capsular contracture remains one of the most common complications
associated with reconstructive breast surgery with an incidence ranging between 0.6% and
30%.6−8
Although numerous theories have been proposed to explain the causes of capsular
contracture, the true etiology has yet to be fully elucidated. Previous studies have shown
that certain factors increase the incidence of capsular contracture, including radiation to
the prosthesis, infection, contamination with foreign material, location of the implant, and
texture of the prosthesis.9−11 Although the literature is replete with theories regarding the
naturalhistoryofperiprostheticcapsuleformation,afactoryettobeadequatelyevaluatedis
the timing of implant exchange. The optimal time interval between the completion of tissue
expansion and placement of the permanent implant is arbitrary and incompletely studied in
the literature.
We theorized that the maturity of the capsule surrounding the tissue expander might
affecttheformationofcapsularcontractureassociatedwiththepermanentimplant.Theaim
of the study was to determine whether the time interval between completion of expansion
andplacementofthepermanentimplantwouldaffecttheincidenceofcapsularcontracture.
PATIENTS AND METHODS
One hundred forty breast reconstructions were studied in 112 breast cancer patients. All
patients underwent postmastectomy tissue expander placement followed by replacement
with permanent breast prosthesis between 1997 and 2004 at our medical center. All sur-
gical procedures were performed by 1 of 3 reconstructive surgeons. Each of the surgeons
utilized a similar operative technique of placing the expander beneath the pectoralis muscle
superiorly, with the inferior and lateral aspects of the expander covered by a flap of serratus
muscleand/orfascia.Capsulotomywasperformedineachpatientwhenthetissueexpander
was replaced with the permanent prosthesis. A consistency of care was noted among the
3 surgeons with each surgeon uniformly administering antibiotics, applying similar post-
operative dressings, and monitoring their patients at similar intervals in the perioperative
periods.
Patients were excluded from the study if their follow-up was less than 12 months after
placementofpermanentprosthesis.Patientswerealsoexcludediftissueexpanderorimplant
was permanently removed. Specifically, patients who required removal of expanders or
implantsbecauseofinfectionorexposureanddidnothavetheirprostheticimplantreplaced
were excluded from the study, as reconstructive course was considered incomplete.
Data were collected retrospectively and maintained in an Excel spreadsheet. Infor-
mation was collected, regarding potential risk factors in the development of capsular
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contracture, including whether the patient smoked cigarettes during the reconstructive pro-
cess or underwent radiation therapy. Radiation therapy as a potential risk factor was further
broken down into 3 categories: whether the patient received chest wall radiation more 5
than years prior to tissue expander placement, within 5 years of tissue expansion, or during
tissue expansion.
Other information collected included whether saline or silicone implants were used
in the reconstruction and the types of complications that required patients to undergo a
reoperation after tissue expander placement and/or after permanent implant placement.
Capsular contracture was graded using the Baker classification, measured clinically
by inspection, palpation, and by subjective reports of pain from the patient. The Baker level
was documented in the clinic notes by the surgeon. Patients with no evidence of capsular
firmness or pain were classified as Baker level I. Those with a palpable, firm capsule were
classified as Baker level II. Patients with a firm capsule and distortion of the implant were
classified as Baker level III. Patients with a firm capsule, distortion of the implant, and with
pain were classified as Baker level IV .
Finally,thetimeintervalbetweencompletionofexpansionandplacementofpermanent
implant was recorded in months.
RESULTS
The mean age of the patients studied was 48 (range = 25–78 years) years. Our average
follow-up was 29 (range = 12–84 months) months after placement of permanent prosthe-
sis. Five percent of patients smoked cigarettes at some point during reconstruction. Sixteen
percent (n = 23) of patients underwent radiation therapy during reconstruction (Table 1) of
the subset of patients who underwent radiation therapy, 17% (n = 4) underwent radiation
therapy more than 5 years prior to the placement of tissue expander; 17% (n = 4) under-
went radiation therapy within 5 years after tissue expander was placed; and 65% (n = 15)
underwent radiation therapy during tissue expansion.
Silicone implants were placed in 46% of patients, whereas saline implants were used
in 54%. Ten percent of patients (n = 14) developed a complication that necessitated reoper-
ation after placement of tissue expander. These complications included hematoma (n = 2);
leak/rupture of the tissue expander (n = 4); partial necrosis of mastectomy flap with threat-
ened exposure (n = 4); seroma (n = 1); wound dehiscence with tissue expander exposure
(n = 2); and infection, including cellulitis (n = 1).
Table 1. Results
Mean age 48 years
Average follow-up time 29 months∗
Patients who smoked cigarettes 5%
Patients who had silicone implants placed 46%
Patients who had saline implants placed 54%
Patients who underwent radiation therapy at some point during reconstruction 16%
∗Time period after placement of permanent prosthesis.
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Figure 1. Complications requiring reoperation.
Fourteen percent (n = 19) of patients developed a complication (other than capsular
contracture) that necessitated reoperation after placement of the permanent implant. These
complicationsincludedinfection/cellulitis(n=5);wounddehiscencewithimplantexposure
(n = 12); and implant rupture (n = 4) (Figure 1). Eighteen percent (n = 25) of patients
developed capsular contracture, Baker grades II to IV .
The median time interval for all patients between completion of tissue expansion and
placement of the permanent implant was 2.5 (range = 0.5–16 months) months. For the
group of patients who developed capsular contracture of their permanent prosthesis, the
median time interval for implant exchange was 2.5 (range = 0.5–7 months) months. For
the patients who did not develop capsular contracture of permanent prosthesis, the median
time interval for implant exchange was 3 (range = 0.5–16 months) months.
We used the statistical software program R 2.3.0 to analyze our data. We formulated
al o gistic regression model that incorporated the potential risk factors to model a binary
result, specifically, whether or not capsular contracture grades II to IV occurred. In our
model, these potential risk factors were radiation, cigarette smoking, complications that
required a reoperation both after the tissue expander was placed and/or after the permanent
prostheses were placed, and the exchange interval between completion of expansion and
placement of the permanent prosthesis.
Keeping all other predictors constant, we found that the time interval between com-
pletion of tissue expansion and placement of the permanent implant had no effect on de-
velopment of capsular contracture. A shorter exchange interval did not change the odds of
developing capsular contracture in our patient population.
Inevaluatingotherpotentialriskfactorsforcapsularcontracture,wefoundthattheonly
significantpredictorofcapsularcontracturewaswhetherthepatientsufferedacomplication
significant enough to warrant a reoperation after the permanent implant was placed (P =
.0001). In our model, keeping all other predictors constant, the odds of developing capsular
contracture were 9 times greater if a reoperation occurred after the permanent implant was
placed than if a reoperation was not necessary.
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Our patients who underwent radiation therapy at any point before or during recon-
structive process had the same odds of developing capsular contracture as the patients who
did not undergo radiation therapy. We also evaluated radiation exposure as an independent
risk factor for the complications that led to reoperation (such as wound dehiscence, infec-
tion, and implant rupture). We found that there was no significant difference in the rate of
complications in patients who were radiated at any point before or during reconstruction as
compared with those who were not radiated.
Similarly, smoking did not significantly affect the odds of developing capsular con-
tracture of the permanent implant.
DISCUSSION
Reconstructive breast surgery continues to evolve. Advances in techniques of tissue expan-
sion, skin-sparing procedures, and microsurgery have broadened the scope of options for
women seeking breast reconstruction. Tissue expansion is a widely used and well-accepted
method of breast reconstruction because it utilizes local tissue to safely reconstruct a breast
mound. A problem inherent to this method, however, is development of a periprosthetic
fibrous capsule that the body produces as a normal response to a foreign body. Hardening
of the capsule, or capsular contracture, remains a frequent complication of this modality of
breast reconstruction. Contracture can compromise the aesthetic outcome, result in pain,
and necessitate further operations.
The etiology of capsular contracture is multifactorial. Whether implants are used in
breast augmentation or breast reconstruction adds another level of complexity to the evalu-
ation of what factors influence contracture. Many studies have investigated the relationship
between contracture and implant surface texture, bacterial colonization, location of implant
placement, and type of implant filler material. There is evidence to suggest that silicone
implants with textured surfaces are associated with significantly less capsular contracture
than those with smooth surfaces.6,12−16 Although not commercially available for use, long-
term studies have shown that polyurethane foam-covered implants may cause the lowest
incidence of capsular contracture.13,17,18 Several studies have shown that bacterial colo-
nization of implants is associated with thicker capsules and a higher frequency of capsular
contracture.19−21 Submuscular placement of breast implants has been consistently shown
to reduce the incidence of capsular contracture. Placement of implants in the submuscular
or subpectoral plane has subsequently become a common practice.22−27 Studies regarding
capsular contracture and filler materials have demonstrated a significantly higher contrac-
ture rate using silicone implants than using saline implants when the implants are placed in
the submuscular plane.28−31
What is less clear in the literature regarding factors involved in capsular contracture
is the role of capsular maturity. The appropriate interval between completion of tissue
expansionandexchangeofthepermanentprosthesisisessentiallyunstudied.Somesurgeons
initially advocated an exchange delay of 6 months after tissue expansion.32 This concept
was further supported by Holmes’ study, in which patients who had a significantly longer
exchange interval between expansion and implant placement had lower rates of capsular
contracturethanpatientswithshorterexchangeintervals.33 Subsequently,thepreferredtime
frame for implant exchange was shortened to 2 months on the basis of the notion that the
majority of contracture occurred during this time.32
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Other authors have evaluated capsular maturity by investigating whether the time
course of expansion affected capsular contracture. Wickman assessed capsular contracture
in women who underwent rapid tissue expansion versus slow tissue expansion, and found
no significant long-term difference in breast softness between the groups.34,35
To our knowledge, the only published study that investigates the timing of implant
exchangeisbyFooetal,whofoundthatdelayingimplantexchangehasnoeffectoncapsular
contracture.36 Our study has produced similar results, suggesting that other factors besides
the maturity of the tissue expander capsule are more significant in producing capsular
contracture of permanent implant.
Our study also showed that complications that occur after the permanent implant was
placed increased the odds of developing contracture. This echoes other studies that have
shown that processes that create inflammation of the capsule predispose to contracture.37,38
What is unique, however, is that when these same complications occurred while the tissue
expanderwasinplace,itdidnotincreasetheoddsofdevelopingcontractureofthepermanent
prosthesis. In other words, inflammatory processes involving the capsule early on do not
necessarily predispose to contracture later. However, inflammatory processes later, that is,
oncethepermanentimplantisinplace,appeartopredisposepatientstocapsularcontracture.
Thiscanbeexplainedby2hypotheses.First,thenatureofthecomplicationsaftertissue
expanderplacementcomparedwiththatafterpermanentimplantplacementwasnotidentical
in this study population. Complications of seroma and hematoma occurred after tissue
expander placement, but not after permanent implant placement. Only 1 patient developed
a significant infection warranting a reoperation after tissue expander placement, whereas
5 patients developed significant infection of their permanent implant. This is because the
majority of patients who lost their tissue expander because of infection (n = 10) opted to
either abort the reconstructive process or undergo autologous tissue transfer. These patients
were excluded from the study. Therefore, this difference likely reflects a selection bias.
Second, the differences in complications associated with tissue expander placement
versus permanent implant placement may reflect the difference in patient-doctor contact
in the postoperative period. During tissue expansion, the surgeon sees the patient weekly
or bimonthly to proceed with expansion. Complications in this period are likely to be
diagnosed early, and serious problems are potentially preempted. In contrast, after the
permanent implant is placed, the patient is typically seen less frequently. It is possible that
subtle complications, such as subclinical infections, went unnoticed by the patient during
thepostoperativeperiod,andthatcomplicationsweremoreadvancedbythetimethepatient
was seen in clinic. More advanced complications may account for the positive correlation
withcapsularcontracture.Thisenumeratestheimportanceofregularandfrequentfollow-up
visits after the permanent implant is placed.
In contrast to other studies, our patients who underwent radiation therapy at any point
before or during their reconstructive process did not have increased odds of developing
capsularcontracture.Thisobservationhasalsobeennotedinotherstudies.Spearsremarked
that, although the number of breast reconstruction patients receiving radiation therapy has
increased by 15%, he has not noted any increases in the rates of capsular contracture.39
One explanation for our finding is the use of improved radiation therapy protocols
at our institution that have also been shown to be well tolerated by patients undergoing
other modalities of breast reconstruction.40 Another explanation for this finding is that in
our institution women who have been radiated or anticipate radiation therapy are offered
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autologous tissue reconstruction. Therefore, only a small percentage (16%) of women in
our study underwent radiation therapy. The power of radiation as a risk factor was thus low
and may explain why radiation therapy did not increase the odds of developing capsular
contracture in our population.
We alsoevaluatedradiationtherapyasanindependentriskfactorforthecomplications
that led to reoperation (such as wound dehiscence, infection, and implant rupture). We
found that there was no significant difference in the rate of complications in patients who
were radiated at any point before or during reconstruction as compared with those who
were not radiated. Again, this is likely explained by both improved protocols for radiation
administration and the low number of patients who received radiation, reducing the power
of radiation therapy as a predictor of complications.
CONCLUSIONS
The time interval between completion of tissue expansion and implant exchange does not
affect the odds of developing capsular contracture. However, inflammatory complications
that necessitate disruption of the periprosthetic capsule of the permanent implant with an
operation significantly increase odds of developing contracture. Finally, it is important to
note that, although the rate of capsular contracture may not be affected by the implant
exchange interval, there may be other reasons to delay implant exchange. The breast soft
tissueenvelopeisexpandedtoincreaseitsvolume,andarecoveryperiodisrequiredtoallow
soft tissue to recover and reestablish blood supply. Thus, some delay between expansion
and implant exchange is necessary to allow this recovery.
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